Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Aflatoxin M1 in Cow%26apos;s Milk: Method Validation for Milk Sampled in Northern Italy
Aflatoxin Contamination of the Milk Supply: A Pakistan Perspective
Aflatoxins in dairy cow feed, raw milk and milk products from Turkey
Aflatoxin B-1 contamination in feed from Puglia and Basilicata regions (Italy): 5 years monitoring data
Aflatoxin M-1 in raw milk and aflatoxin B-1 in feed from household cows in Singida, Tanzania
Aflatoxins and ochratoxin A in dried eggplant and green bell pepper
Aflatoxins, hydroxylated metabolites, and aflatoxicol from breast muscle of laying hens
Aflatoxins: Climate change and biodegradation
Aflatoxin B1-induced epigenetic alterations: An overview
Aflatoxin B1 Electrochemical Aptasensor Based on Tetrahedral DNA Nanostructures Functionalized Three Dimensionally Ordered Macroporous MoS2-AuNPs Film
Aflatoxin B1 and/or Hepatitis B Virus Induced Tumor Spectrum in a Genetically Engineered Hepatitis B Virus Expression and Trp53 Haploinsufficient Mouse Model System for Hepatocarcinogenesis
Aflatoxins in peanut oil: food safety concerns
Aflatoxin contamination and exposure in processed cereal-based complementary foods for infants and young children in greater Accra, Ghana
Aflatoxins: Implications on Health
Aflatoxin B-1 and sterigmatocystin in wheat and wheat products from supermarkets in China
Aflatoxin binding efficiency of Saccharomyces cerevisiae mannoprotein in contaminated pistachio nuts
Aflatoxin B1, ochratoxin A and zearalenone in sorghum grains marketed in Tunisia
Aflatoxin M1 in Nili-ravi buffaloes and its detoxification using organic and inorganic toxin binders
Aflatoxin - Publication analysis of a global health threat
Aflatoxin exposure in Nigerian children with severe acute malnutrition
Aflatoxins and ochratoxin A in different cocoa clones (Theobroma cacao L.) developed in the southern region of Bahia, Brazil
Aflatoxins Contamination in Maize Products from Rural Communities in San Luis Potosi, Mexico
Aflatoxin B1 impairs sperm quality and fertilization competence
Aflatoxin B-1-contaminated diet disrupts the blood brain barrier and affects fish behavior: Involvement of neurotransmitters in brain synaptosomes
Aflatoxin B1 reduces non-enzymatic antioxidant defenses and increases protein kinase C activation in the cerebral cortex of young rats
Aflatoxigenic and ochratoxigenic fungi and their mycotoxins in spices marketed in Brazil
Aflatoxin B-1 induced multiple epigenetic modulators in human epithelial cell lines
Aflatoxin B-1 affects apoptosis and expression of death receptor and endoplasmic reticulum molecules in chicken spleen
Aflatoxin B1 Promotes Influenza Replication and Increases Virus Related Lung Damage via Activation of TLR4 Signaling.
Aflatoxin B-1 degradation by salt tolerant Tetragenococcus halophilus CGMCC 3792
Aflatoxin B-1 Degradation and Detoxification by Escherichia coli CG1061 Isolated From Chicken Cecum
Aflatoxin G(1) induced TNF-alpha-dependent lung inflammation to enhance DNA damage in alveolar epithelial cells
Aflibercept (VEGF Trap): one more double-edged sword of anti-VEGF therapy for cancer?
Aflibercept for Central Retinal Vein Occlusion: An Ongoing Revolution or Are We Spinning in Place?
Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial
Aflibercept-Related Sterile Inflammation
Aflibercept in the Treatment of Neovascular Age-Related Macular Degeneration in Previously Treated Patients
Aflibercept: Newly Approved for the Treatment of Macular Edema Following Central Retinal Vein Occlusion
Aflibercept-a Decoy VEGF Receptor
Aflibercept for the treatment of refractory polypoidal choroidal vasculopathy
Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: Prespecified subgroup analyses from the VELOUR trial
Aflibercept Therapy for Exudative Age-related Macular Degeneration Resistant to Bevacizumab and Ranibizumab
Aflibercept in lung cancer
Aflibercept in wet AMD: specific role and optimal use
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
Aflibercept therapy for polypoidal choroidal vasculopathy: short-term results of a multicentre study
Aflibercept Plus FOLFIRI vs. Placebo Plus FOLFIRI in Second-Line Metastatic Colorectal Cancer: a Post Hoc Analysis of Survival from the Phase III VELOUR Study Subsequent to Exclusion of Patients who had Recurrence During or Within 6 Months of Completing Adjuvant Oxaliplatin-Based Therapy
Aflibercept anti-vascular endothelial growth factor therapy in vitrectomized eyes with neovascular age-related macular degeneration
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial
Aflibercept, a New Way to Target Angiogenesis in the Second Line Treatment of Metastatic Colorectal Cancer (mCRC)
Aflibercept in persistent neovascular AMD: comparison of different treatment strategies in switching therapy
Aflibercept and Ang1 supplementation improve neoadjuvant or adjuvant chemotherapy in a preclinical model of resectable breast cancer
Aflibercept Exerts Antivascular Effects and Enhances Levels of Anthracycline Chemotherapy In vivo in Human Acute Myeloid Leukemia Models
Aflibercept and Docetaxel Versus Docetaxel Alone After Platinum Failure in Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer: A Randomized, Controlled Phase III Trial
Aflibercept for exudative AMD with persistent fluid on ranibizumab and/or bevacizumab
Aflibercept (VEGF Trap) in Inoperable Stage III or Stage IV Melanoma of Cutaneous or Uveal Origin
Aflibercept: A Novel VEGF Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Tumors
Aflibercept (AVE0005): an alternative strategy for inhibiting tumour angiogenesis by vascular endothelial growth factors
Aflibercept-mediated early angiogenic changes in aggressive B-cell lymphoma
Aflibercept for Intravitreal Injection In Neovascular Age-Related Macular Degeneration
Aflibercept, a New Way to Target Angiogenesis in the Second Line Treatment of Metastatic Colorectal Cancer (mCRC) (vol 11, pg 489, 2016)
Aflibercept in persistent neovascular AMD: comparison of different treatment strategies in switching therapy
Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option
Afline q-deformed symmetry and the classical Yang-Baxter sigma-model
Aflibercept-related nasal septum perforation
Aflibercept in wet AMD beyond the first year of treatment: recommendations by an expert roundtable panel
Aflibercept Traps Galectin-1, an Angiogenic Factor Associated with Diabetic Retinopathy
Aflibercept, bevacizumab and ranibizumab prevent glucose-induced damage in human retinal pericytes in vitro, through a PLA(2)/COX-2/VEGF-A pathway
Aflibercept administration in neovascular age-related macular degeneration refractory to previous anti-vascular endothelial growth factor drugs: a critical review and new possible approaches to move forward
Aflibercept improves outcome in eyes with poor vision from neovascular age-related macular degeneration
Aflibercept as a Second Line Therapy for Neovascular Age Related Macular Degeneration in Israel (ASLI) study
Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option
Aflibercept for Age-Related Macular Degeneration: A Game-Changer or Quiet Addition?
Aflibercept as First-Line Therapy in Patients with Treatment-Naive Neovascular Age-Related Macular Degeneration: Prospective Case Series Analysis in Real-Life Clinical Practice
Aflibercept for neovascular age-related macular degeneration
Aflibercept in the treatment of diabetic macular edema: a review and consensus paper
Aflibercept for diabetic macular oedema: a Meta-analysis of randomized controlled trials
Aflp linkage map of an intraspecific cross in Chlamys farreri
Aflunov (R): a vaccine tailored for pre-pandemic and pandemic approaches against influenza
Aflunov (R): a prepandemic influenza vaccine
Afmite, Al-3(OH)(4)(H2O)(3)(PO4)(PO3OH)center dot H2O, a new mineral from Fumade, Tarn, France: description and crystal structure
Afobazole Activation of sigma-1 Receptors Modulates Neuronal Responses to Amyloid-beta(25-35)
Afobazole Modifies the Neurotoxic and Genotoxic Effects in Rat Prenatal Alcoholization Model